EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)
Clinical trial NCT04516161 · COMPLETED
Trial details
- NCT number
- NCT04516161
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-03
- Primary completion
- 2021-03-31
- Enrollment
- 1180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.